Literature DB >> 14755656

Longitudinal MRI tracking of the angiogenic response to hind limb ischemic injury in the mouse.

Keren Ziv1, Nava Nevo, Hagit Dafni, Tomer Israely, Dorit Granot, Ori Brenner, Michal Neeman.   

Abstract

Ischemic injury and revascularization are frequently associated with hyperpermeability. Although extravasation of plasma proteins may promote tissue recovery through the generation of the provisional matrix that supports angiogenesis, edema may also result in progressive damage to the muscle. The aim of this research was to determine the time course of hyperpermeability associated with the angiogenic response induced by ligation of the femoral artery at the right posterior limb in mice. Hyperpermeability was followed noninvasively by MRI using an in-house-built permanent polyethylene catheter that enabled daily intravenous administration of biotin-BSA-Gd-DTPA. The mice were scanned once prior to ligation and five times during the week post-ligation. The MRI data, along with histopathology, indicated that the early hemodynamic compensation over loss of arterial blood supply occurred by angiogenesis and dilation of vessels in the skin and subcutaneous fat, and was accompanied by vascular hyperpermeability around the site of ligation. Functional recovery of the ischemic limb (i.e., regaining the ability to step on the limb), and the color and shape of the toes correlated with regeneration as shown by histopathology and MRI analysis. Thus, MRI provided valuable information on the transient hyperpermeability induced during the early stages of angiogenesis, and its subsequent resolution along with functional recovery from acute hind limb ischemia in mice. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14755656     DOI: 10.1002/mrm.10687

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  7 in total

Review 1.  Dynamic contrast-enhanced magnetic resonance imaging: fundamentals and application to the evaluation of the peripheral perfusion.

Authors:  Yaron Gordon; Sasan Partovi; Matthias Müller-Eschner; Erick Amarteifio; Tobias Bäuerle; Marc-André Weber; Hans-Ulrich Kauczor; Fabian Rengier
Journal:  Cardiovasc Diagn Ther       Date:  2014-04

2.  The role of heparanase in lymph node metastatic dissemination: dynamic contrast-enhanced MRI of Eb lymphoma in mice.

Authors:  Hagit Dafni; Batya Cohen; Keren Ziv; Tomer Israely; Orit Goldshmidt; Nava Nevo; Alon Harmelin; Israel Vlodavsky; Michal Neeman
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

3.  Bone vascularization and trabecular bone formation are mediated by PKB alpha/Akt1 in a gene-dosage-dependent manner: in vivo and ex vivo MRI.

Authors:  Katrien Vandoorne; Jeremy Magland; Vicki Plaks; Amnon Sharir; Elazar Zelzer; Felix Wehrli; Brian A Hemmings; Alon Harmelin; Michal Neeman
Journal:  Magn Reson Med       Date:  2010-07       Impact factor: 4.668

Review 4.  Visualizing vascular permeability and lymphatic drainage using labeled serum albumin.

Authors:  Katrien Vandoorne; Yoseph Addadi; Michal Neeman
Journal:  Angiogenesis       Date:  2010-05-29       Impact factor: 9.596

5.  Macromolecular dynamic contrast-enhanced (DCE)-MRI detects reduced vascular permeability in a prostate cancer bone metastasis model following anti-platelet-derived growth factor receptor (PDGFR) therapy, indicating a drop in vascular endothelial growth factor receptor (VEGFR) activation.

Authors:  Hagit Dafni; Sun-Jin Kim; James A Bankson; Madhuri Sankaranarayanapillai; Sabrina M Ronen
Journal:  Magn Reson Med       Date:  2008-10       Impact factor: 4.668

6.  Quantitative analysis of peripheral tissue perfusion using spatiotemporal molecular dynamics.

Authors:  Yujung Kang; Myunghwan Choi; Jungsul Lee; Gou Young Koh; Kihwan Kwon; Chulhee Choi
Journal:  PLoS One       Date:  2009-01-26       Impact factor: 3.240

7.  Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery.

Authors:  A B Katwal; P R Konkalmatt; B A Piras; S Hazarika; S S Li; R John Lye; J M Sanders; E A Ferrante; Z Yan; B H Annex; B A French
Journal:  Gene Ther       Date:  2013-03-28       Impact factor: 5.250

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.